| Guidelines on the management of abnormal liver blood tests PN Newsome, R Cramb, SM Davison, JF Dillon, M Foulerton, EM Godfrey, ... Gut 67 (1), 6-19, 2018 | 500 | 2018 |
| The British Society of Gastroenterology/UK-PBC primary biliary cholangitis treatment and management guidelines GM Hirschfield, JK Dyson, GJM Alexander, MH Chapman, J Collier, ... Gut 67 (9), 1568-1594, 2018 | 352 | 2018 |
| British Society of Gastroenterology and UK-PSC guidelines for the diagnosis and management of primary sclerosing cholangitis MH Chapman, D Thorburn, GM Hirschfield, GGJ Webster, SM Rushbrook, ... Gut 68 (8), 1356-1378, 2019 | 253 | 2019 |
| Non-alcoholic fatty liver disease: A patient guideline SM Francque, G Marchesini, A Kautz, M Walmsley, R Dorner, JV Lazarus, ... JHEP reports 3 (5), 100322, 2021 | 198 | 2021 |
| Factors associated with outcomes of patients with primary sclerosing cholangitis and development and validation of a risk scoring system EC Goode, AB Clark, GF Mells, B Srivastava, K Spiess, WTH Gelson, ... Hepatology 69 (5), 2120-2135, 2019 | 78 | 2019 |
| Top research priorities in liver and gallbladder disorders in the UK KS Gurusamy, M Walmsley, BR Davidson, C Frier, B Fuller, A Madden, ... BMJ open 9 (3), e025045, 2019 | 21 | 2019 |
| The Primary Sclerosing Cholangitis (PSC) Wellbeing Study: Understanding psychological distress in those living with PSC and those who support them V Ranieri, E Kennedy, M Walmsley, D Thorburn, K McKay PLoS One 15 (7), e0234624, 2020 | 18 | 2020 |
| Prevalence of COVID‐19 in patients with autoimmune liver disease in Europe: A patient‐oriented online survey BF Zecher, G Buescher, J Willemse, M Walmsley, A Taylor, A Leburgue, ... UEG Journal 9 (7), 797-808, 2021 | 15 | 2021 |
| British Society of Gastroenterology guidelines for the diagnosis and management of cholangiocarcinoma SM Rushbrook, TJ Kendall, Y Zen, R Albazaz, P Manoharan, SP Pereira, ... Gut 73 (1), 16-46, 2024 | 13 | 2024 |
| Liver disease in the UK GM Hirschfield, C Thain, M Walmsley, A Brownlee, DE Jones The Lancet 385 (9967), 503, 2015 | 11 | 2015 |
| Primary sclerosing cholangitis and psychological wellbeing: a scoping review V Ranieri, K McKay, M Walmsley, R Senior, D Thorburn, E Kennedy Seminars in Liver Disease 39 (01), 104-110, 2019 | 10 | 2019 |
| Identifying research priorities in primary sclerosing cholangitis: driving clinically meaningful change from the patients’ perspective M Walmsley, A Leburgue, D Thorburn, G Hirschfield, P Trivedi J Hepatol 70 (1), e412-e413, 2019 | 9 | 2019 |
| Rare but heard: using asynchronous virtual focus groups, interviews and roundtable discussions to create a personalised psychological intervention for primary sclerosing … V Ranieri, E Kennedy, M Walmsley, D Thorburn, K McKay BMJ open 9 (10), e031417, 2019 | 6 | 2019 |
| A nationwide population-based evaluation of mortality and cancer-risk in patients with ulcerative colitis/primary sclerosing cholangitis–young age at diagnosis and the unmet … P Trivedi, J Mytton, F Evison, SK Kamarajah, J Reece, T Iqbal, R Cooney, ... Journal of Hepatology 68, S220-S221, 2018 | 6 | 2018 |
| Autoimmune hepatitis-learning about your patients from their autoantibody profiles. M Corrigan, GMR Hirschfield, YH Oo, DH Adams, C Thain, M Walmsley, ... Journal of Hepatology 12 (2), 5-7, 2014 | 5 | 2014 |
| Quality of life (QoL) for people with primary sclerosing cholangitis (PSC): a pragmatic strategy for identifying relevant QoL issues for rare disease E Marcus, P Stone, D Thorburn, M Walmsley, B Vivat Journal of Patient-Reported Outcomes 6 (1), 76, 2022 | 4 | 2022 |
| Patient‐reported quality of care in primary sclerosing cholangitis M Walmsley, D Tornai, N Cazzagon, A Leburgue, A Mrzljak, H Lenzen, ... Liver International 43 (8), 1654-1662, 2023 | 3 | 2023 |
| Coeliac disease. AVS Sarma | 3 | 1952 |
| P34 Burden, impact and variability of pruritus in primary sclerosing cholangitis (PSC) over time: a prospective observational study N Hussain, B Hirschfield, J Ferguson, N Abbas, K Bhandal, P Rogers, ... Gut 72 (Suppl 3), A34-A35, 2023 | 2 | 2023 |
| Surveillance for cholangiocarcinoma in patients with primary sclerosing cholangitis: Can we be more proactive? D Gleeson, M Walmsley, PJ Trivedi, D Joshi, B Rea Frontline Gastroenterology 14 (2), 162-166, 2023 | 1 | 2023 |
